Rigel Pharmaceuticals Inc
RIGL· Nasdaq
RIGLRigel Pharmaceuticals Inc
Released Nov 1, 2016, after the close
10-Q filed Nov 1, 2016, 32 days after period end · 0001558370-16-008977
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Net Income | -$22.63M | — | — | — |
| EPS Diluted | -$0.24 | -$0.08 | -$0.24 | -$0.27 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Sep 30, 2016 · filed Nov 1, 2016 · 32 d after period end
2.3% from the close of Nov 1, 2016 to the close of Nov 2, 2016, the first after the release.
